Correlation Between Franklin Genomic and Franklin Disruptive

Can any of the company-specific risk be diversified away by investing in both Franklin Genomic and Franklin Disruptive at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Genomic and Franklin Disruptive into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Franklin Genomic Advancements and Franklin Disruptive Commerce, you can compare the effects of market volatilities on Franklin Genomic and Franklin Disruptive and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Genomic with a short position of Franklin Disruptive. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Genomic and Franklin Disruptive.

Diversification Opportunities for Franklin Genomic and Franklin Disruptive

-0.64

Correlation Coefficient

Franklin Genomic  Franklin Disruptive

Excellent diversification

The 3 months correlation between Franklin and Franklin is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Genomic Advancements and Franklin Disruptive Commerce in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Franklin Disruptive and Franklin Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Genomic Advancements are associated (or correlated) with Franklin Disruptive. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Franklin Disruptive has no effect on the direction of Franklin Genomic i.e., Franklin Genomic and Franklin Disruptive go up and down completely randomly.

Pair Corralation between Franklin Genomic and Franklin Disruptive

Given the investment horizon of 90 days Franklin Genomic Advancements is expected to under-perform the Franklin Disruptive. In addition to that, Franklin Genomic is 1.34 times more volatile than Franklin Disruptive Commerce. It trades about -0.11 of its total potential returns per unit of risk. Franklin Disruptive Commerce is currently generating about 0.28 per unit of volatility. If you would invest  3,312  in Franklin Disruptive Commerce on September 16, 2024 and sell it today you would earn a total of  577.00  from holding Franklin Disruptive Commerce or generate 17.42% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Franklin Genomic Advancements  vs.  Franklin Disruptive Commerce

Franklin Genomic Adv

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Franklin Genomic Advancements has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Etf's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Franklin Disruptive

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Franklin Disruptive Commerce are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Franklin Disruptive showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Franklin Genomic and Franklin Disruptive

The main advantage of trading using opposite Franklin Genomic and Franklin Disruptive positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Genomic position performs unexpectedly, Franklin Disruptive can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Franklin Disruptive will offset losses from the drop in Franklin Disruptive's long position.

The idea behind Franklin Genomic Advancements and Franklin Disruptive Commerce pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.